Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sacred Heart installs Talyst pharmacy automation solution
By using AutoCarousel, the Medical Center is able to consolidate its drug inventory in a compact footprint, while AutoLabel has improved patient safety by barcoding and labeling all
By using AutoCarousel, the Medical Center is able to consolidate its drug inventory in a compact footprint, while AutoLabel has improved patient safety by barcoding and labeling all
The company’s abbreviated new drug application (ANDA) may be delayed for up to six months following the agency’s decision. Watson has filed a suit after communicating with FDA
The company has developed For Your Health – Calcium & Vitamin D as part of Nouveau Life’s focus on health concerns for aging adults and is at present
The multicentre, open-label study is designed to assess safety and tolerability of SOR-C13, in addition to pharmacokinetics, biomarkers and initial evidence for efficacy. Soricimed Biopharma chairman and chief
The drug is used to treat manic episodes of manic depressive illness. According to IMS Health, Lithium Carbonate Extended-release Tablets USP, 450 mg, had US sales of around
The 33,000ft² facility is designed to fulfill capacity expansion and meet the increasing demand of India’s packaging market as well as international markets. Bosch managing director V K
AEZS-130, which has been granted orphan drug designation by the FDA, is an orally-active small molecule that stimulates the secretion of adult growth hormone. The company has completed
The Phase 3 program comprises two efficacy studies, one in opioid naive and one in opioid experienced subjects, along with an open-label safety study. Both efficacy studies, which
The Provincial Health Office Junelyn Abellon said the product is a micronutrient powder, which contains iron, vitamins. "This additional supplement is part of the Garantisadong Pambata program of
As part of the acquisition, Merus Labs will manufacture, market, and sell darifenacin, used to treat overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. The